DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome. METHODS: This was a prospective, multinational pharmacokinetic point-prevalence study including 8 β-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f T>MIC) and 100% (100% f T>MIC) of the dosing interval. We used skewed logistic regression to describe the effect of antibiotic exposure on patient outcome. RESULTS: We included 384 patients (361 evaluable patients) across 68 hospitals. The median age was 61 (interquartile range [IQR], 48-73) years, the median Acute Physiology and Chronic Health Evaluation II score was 18 (IQR, 14-24), and 65% of patients were male. Of the 248 patients treated for infection, 16% did not achieve 50% f T>MIC and these patients were 32% less likely to have a positive clinical outcome (odds ratio [OR], 0.68; P = .009). Positive clinical outcome was associated with increasing 50% f T>MIC and 100% f T>MIC ratios (OR, 1.02 and 1.56, respectively; P < .03), with significant interaction with sickness severity status. CONCLUSIONS: Infected critically ill patients may have adverse outcomes as a result of inadeqaute antibiotic exposure; a paradigm change to more personalized antibiotic dosing may be necessary to improve outcomes for these most seriously ill patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association (167,(171)(172)(173).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [171]
In the citing paper
“Antibiotics are subject to changes in PK/PD parameters in sepsis and septic shock where resultant concentrations may be too low risking clinical failure, or too high leading to toxicity (Table 3) [237–239].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [238]
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“Various demographic and clinical data were collected including age, sex, height, weight, presence of renal replacement therapy, and measures of organ function and levels of patient sickness severity as described by the APACHE II (Acute Physiology and Chronic Health Evaluation II) score [15] on admission and SOFA (Sequ…”
MethodKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 1×
“From a pharmacokinetic/pharmacodynamic (PK/PD) perspective, preclinical studies have defined these antibiotics to be time dependent, that is, the time for which the free (unbound) antibiotic concentration is maintained above the minimum inhibitory concentration (MIC) is the determinate factor associated with bacterial…”
BackgroundAntimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930 · cited 1×
“Whereas animal in vivo studies have defined an f T>MIC between 40% and 70% of the dosing interval as being necessary [11], retrospective clinical evaluations have suggested that larger drug exposures are required, with β-lactam concentrations up to 4 times the MIC for the entire dosing interval being suggested [12, 13…”
BackgroundHarbarth, S., Garbino, J., Pugin, J., Romand, J. A., Lew, D., & Pittet, D. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.005 · Cited by 637
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464 · cited 2×
“Whereas animal in vivo studies have defined an f T>MIC between 40% and 70% of the dosing interval as being necessary [11], retrospective clinical evaluations have suggested that larger drug exposures are required, with β-lactam concentrations up to 4 times the MIC for the entire dosing interval being suggested [12, 13…”
BackgroundResultSubtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
Udy, A. A., Varghese, J. M., Altukroni, M., Briscoe, S., McWhinney, B. C., Ungerer, J. P., Lipman, J., & Roberts, J. A. (2012) · Chest · doi:10.1378/chest.11-1671 · Cited by 414 · cited 1×
“These patients may have augmented renal clearances needing either higher doses or more frequent dosing to overcome increased drug elimination [22, 23].”
BackgroundSelf-citationAntibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira, J., & Póvoa, P. (2011) · Critical Care · doi:10.1186/cc10441 · Cited by 408 · cited 2×
“It has been suggested that superior infection outcomes could be achieved in critically ill patients by optimization of the pharmacokinetic exposure of antibiotics [5, 6].”
Background
Cited by
Items 801–900 of 1,000
Martín‐Loeches, I., Léone, M., Reyes, L. F., Morris, A. C., Russell, L., Teoh, T. K., & Rodríguez, Á. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2663102 · Cited by 3
Williams, P. G., Cotta, M. O., Abdul-Aziz, M. H., Wilks, K. M., Murray, L., Wallis, S. C., Beall, G., & Roberts, J. A. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107883 · Cited by 3
Self-citationInamdar, A., Beeraka, N. M., Vikram, P. R. H., Gurupadayya, B. M., Sanathan, S. R., Prashant, A., Kumar, T. P., Nikolenko, V. N., Reddy, Y. P., Kandula, D. R., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761582 · Cited by 3
Ricci, Z., Benegni, S., Cies, J. J., Marinari, E., Haiberger, R., Garisto, C., Cairoli, S., Chiara, L. D., & Goffredo, B. M. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002179 · Cited by 3
Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study
Selig, D. J., Kress, A. T., Nadeau, R. J., & DeLuca, J. P. (2023) · Antibiotics · doi:10.3390/antibiotics12030444 · Cited by 3
“Although there are signals that achieving higher PD targets may be associated with improved clinical outcomes, these signals are often derived from secondary analyses and may be prone to bias [40].”
BackgroundMaranchick, N. F., Webber, J., Al‐Shaer, M. H., Felton, T., & Peloquin, C. A. (2023) · Antibiotics · doi:10.3390/antibiotics12121696 · Cited by 3
Antibiotics in anesthesia and critical care
Premachandra, A., & Moine, P. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-5585 · Cited by 3
“Underdosing of antibiotics is thus frequent in ICU patients, and these patients are less likely to have positive clinical outcome (6,55).”
InfluentialWu, Y.-L., Lu, Z., Liang, P., Zhu, H., Qi, H., & Zhang, H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02909-4 · Cited by 3
“Imipenem is one of the most commonly used in the intensive care unit (ICU), and optimal efficacy is achieved at 100%fT>MIC in critically ill patients (Hayashi et al. 2013;Roberts et al. 2010; Roberts et al. 2014).”
Schmid, S. A., Zimmermann, K., Koch, C., Mester, P., Athanasoulas, G., Buttenschoen, J., Fleischmann, D., Schlosser‐Hupf, S., Pavel, V., Schilling, T., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14020202 · Cited by 3
Bastin, M. L. T., Rech, M. A., Betthauser, K. D., Heavner, M. S., Horng, M., Lemieux, S. M., Lumpkin, M., McCreary, E. K., Ruggero, M. A., Wieruszewski, P. M., et al. (2025) · CMI Communications · doi:10.1016/j.cmicom.2025.105084 · Cited by 3
Lee, Y. J., Kang, G., Zang, D. Y., & Lee, D. H. (2025) · Pharmaceuticals · doi:10.3390/ph18081124 · Cited by 3
D’Agostino, C., Rhodes, N. J., Skoglund, E. W., Roberts, J. A., & Scheetz, M. H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.05.010 · Cited by 3
“The DALI Study also showed that an increasing f%T>MIC ratiowas associatedwith increased likelihood of positive clinical outcome, therefore providing preliminary support for use of doses that exceed the standard beta-lactam target of 50% f T>MIC [6].”
BackgroundResultSelf-citationPharmacological Considerations in Acute and Chronic Liver Disease
Peppard, W., Killian, A. J., & Biesboer, A. N. (2018) · Springer eBooks · doi:10.1007/978-3-319-66432-3_17 · Cited by 3
Diagnosis and Management of Sepsis and Septic Shock: An Evidence-Based Review
Tulli, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-94189-9_9 · Cited by 3
The role of antibiotic pharmacokinetic studies performed post-licensing
Parker, S. L., Abdul-Aziz, M. H., & Roberts, J. A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106165 · Cited by 6
Self-citationDigital biomarkers from sweat analysis for therapeutic drug monitoring in soft tissue infections
Brasier, N., Widmer, A. F., Osthoff, M. F., & Eckstein, J. (2021) · doi:10.1145/3469266.3471179 · Cited by 3
Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics
Mo, Y., Shcherbakova, N., Inman, K. L., Li, W. K., Kovalenko, K., Rosenberg, J. R., Orsini, J., & Truong, J. Q. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1967 · Cited by 3
“Clinical failure was considered if the patient met one of the following criteria: (1) persistence or progression of signs and symptoms of pneumonia on day 7; (2) progression of radiographic signs of pneumonia on day 7; (3) discontinuation of cefepime due to lack of efficacy and/or the initiation of an alternative agen…”
MethodHow Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?
de Montmollin, É., & Timsit, J. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733987 · Cited by 3
Mitton, B. C., Paruk, F., Gous, A. G., Chausse, J., Milne, M., Becker, P., & Said, M. (2022) · South African Medical Journal · doi:10.7196/samj.2022.v112i9.16371 · Cited by 3
Salehi, M., Rezazade-Moayed, F., Khalili, H., Hemati, H., Aghdami, N., Dashtkoohi, M., Dashtkoohi, M., Beigmohammadi, M. T., Ramezani, M., Hajiabdolbaghi, M., et al. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0170 · Cited by 3
Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report
Kim, S., Stucky, N. L., Drummond, W. K., Elbarbry, F., & Footer, B. W. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2832 · Cited by 3
Damgaard, T., Woksepp, H., Brudin, L. H., Bonnedahl, J., Nielsen, E. I., Schön, T., & Hällgren, A. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2024.2323002 · Cited by 5
Li, H., Jiang, M., & Kong, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1474878 · Cited by 4
In vitro elimination of antimicrobials during ADVanced Organ Support hemodialysis
König, C., Frey, O. R., Himmelein, S., Mulack, L., Brinkmann, A., de Garibay, A. P. R., & Bingold, T. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1447511 · Cited by 3
Medikamentendosierung unter extrakorporaler Therapie
Kielstein, J. T. (2014) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-014-0349-0 · Cited by 3
Is there a role for continuous infusion of β-lactam antibiotics in severe sepsis?
Bates, A., & Joffe, A. R. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.03.81 · Cited by 3
Current Clinical Controversies in the Management of Sepsis
Cohen, J. (2016) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2016.413 · Cited by 3
Clinical Outcomes With Continuous Nafcillin Infusions in Children
Knoderer, C. A., Karmire, L. C., & Nichols, K. R. (2017) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-22.4.261 · Cited by 3
β-lactam microneedle array biosensors: a new technology on the horizon
Richter, D., & Weigand, M. A. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30126-8 · Cited by 3
Sadilová, K., Halačová, M., & Černý, D. (2020) · Česká a slovenská farmacie · doi:10.36290/csf.2020.002 · Cited by 3
Jin, Y., Mao, H., Bingyang, L., Zhou, F., Yang, J., Xu, L., Tong, J., Huang, C., & Ding, Y. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s284754 · Cited by 3
Dosierung von Antibiotika bei Nierenfunktionsstörung und kontinuierlicher Nierenersatztherapie
Michael, E., & Kindgen‐Milles, D. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0008-8 · Cited by 3
Standard of practice in infectious diseases for pharmacy services
Cairns, K. A., Avent, M. L., Buono, E., Cheah, R., Devchand, M., Khumra, S., Rawlins, M. D. M., Roberts, J. A., Xenos, K., & Munro, C. (2021) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1744 · Cited by 3
Self-citationde Velde, F., de Winter, B. C. M., Neely, M. N., Strojil, J., Yamada, W. M., Harbarth, S., Huttner, A., van Gelder, T., Koch, B. C. P., Muller, A. E., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122170 · Cited by 3
Evaluation of plasma levels of meropenem in septic patients during extracorporeal blood purification
Marukhov, A. V., Murzina, E. V., Владимирович, З. М., Софронов, Г. А., Buryakova, L. V., Ivanov, M. B., Журкович, И. К., & Ostrovidova, E. V. (2021) · Medical academic journal · doi:10.17816/maj54636 · Cited by 3
Amikacin dosing in the ICU: we now know more, but still not enough…
Rosa, F. G. D., & Roberts, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3308-6 · Cited by 3
Self-citationFocus on adequate antimicrobial treatment and de-escalation in the ICU
Benoît, D., Doig, G. S., & Timsit, J. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4566-2 · Cited by 3
Yoshihiro, S., & Taito, S. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06648-7 · Cited by 3
Comment on: Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
Giuliano, S., Angelini, J., Flammini, S., & Tascini, C. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac109 · Cited by 3
Editorial: Progressing the understanding and management of bloodstream infections
Wang, L., Lin, B., Gong, X., & Yu, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1562934 · Cited by 3
Adamiszak, A., Bartkowska‐Śniatkowska, A., Grześkowiak, E., & Bienert, A. (2024) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2024.141332 · Cited by 2
Stommel, A.-M., Matzneller, P., al Jalali, V., Wulkersdorfer, B., Lackner, E., Müeller, M., Dorn, C., Holzer, M. S., & Zeitlinger, M. A. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-025-01497-1 · Cited by 4
“In a large multinational study on beta-lactams (including AMO and AMP) in critically ill patients, plasma concentrations varied significantly, leading to inconsistent achievement of pharmacokinetic targets [30].”
Momčilović, M., Šitum, I., Erceg, A., Siroglavić, M., Lovrić, M., Nodilo, L. N., Hafner, A., Lovrić, J., Turčić, P., Fabijanović, D., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1618987 · Cited by 2
Baulier, C., Giry, M., Etienne, M., Kallout, J., & Alexandre, K. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2025.10.009 · Cited by 2
Sulaiman, H., Rozali, M. A., Adiraju, S. K. S., Hasan, M. S., Jamal, J., Liu, X., Nor, M. B. M., Mazlan, M. Z., Jailani, M. I. O., Salmuna, Z. N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-20630-5 · Cited by 2
Self-citationTian, S., Chen, Y., Qiu, M., Wu, W., Dou, L., Wang, J., Xu, L., Zhou, Z., Wu, M., Li, J., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05343-x · Cited by 2
Dzierba, A. L., Liang, Y., & Lyster, H. S. (2025) · JHLT Open · doi:10.1016/j.jhlto.2025.100438 · Cited by 3
Boer-Pérez, F. S., Lima‐Rogel, V., Romano‐Moreno, S., Mejía-Elizondo, A. R., Medellín‐Garibay, S. E., Schaiquevich, P. S., Noyola, D. E., Rodríguez‐Báez, A. S., Rodríguez‐Pinal, C. J., & Milán‐Segovia, R. D. C. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00998-25 · Cited by 2
Beta-lactam dose reductions in critically ill patients with acute kidney injury: a scoping review
Horstink, M. M. B., Rietdijk, W. J. R., Geel, D. R., Deetman, P. E., Endeman, H., Koch, B. C. P., & den Uil, C. A. (2025) · Critical Care · doi:10.1186/s13054-025-05736-6 · Cited by 2
Zhou, Y. P., Chung, S. J., Lee, W. H. L., Wang, Y., Lim, S. Y. C., Tan, Y. E., & Kwa, A. L. (2025) · Antibiotics · doi:10.3390/antibiotics14121239 · Cited by 2
Antimicrobial stewardship in critical care
Nolan, T. J., & Martín‐Loeches, I. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2600243 · Cited by 4
Gatti, M., & Pea, F. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2609700 · Cited by 2
“Unfortunately, attaining an early aggressive PK/PD target of beta-lactams may be difficult among the critically ill patients, since the proportion of failure after administering standard dosing regimens was shown to be as high as 60% of cases [19–23].”
Shah, S., Peng, L., Clarke, L. G., Balasubramani, G. K., Smith, B. J., & Shields, R. K. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf498 · Cited by 2
Paghaleh, H. J., Jahani, S., Moradalizadeh, M., & Foroughi, M. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-36658-0 · Cited by 2
Meslamani, A. Z. A., Jarab, A. S., & Mohammed, E. M. A. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2638352 · Cited by 2
Vale, C., Sime, F. B., Cotta, M. O., Eriksson, L., Roberts, J. A., Horvath, R. L., & Abdul-Aziz, M. H. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkag142 · Cited by 2
Self-citationManaging sepsis in the era of precision medicine: a narrative review
Yong, H. J., Kim, S., & Kim, D. (2026) · Acute and Critical Care · doi:10.4266/acc.000884 · Cited by 2
“Consequently, continuous or prolonged infusion has been proposed to maximize fT>MIC [40].”
Tebano, G., Convertino, C., Raumer, L., Sgarzani, R., Melandri, D., & Cristini, F. (2026) · European Burn Journal · doi:10.3390/ebj7020035 · Cited by 2
Drug Dosing in Continuous Renal Replacement Therapy
Wong, A., Kane‐Gill, S. L., & Kellum, J. A. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780190225537.003.0020 · Cited by 2
Antimicrobial Resistance Profile in ICUs of Tertiary Care Hospital—A Worrisome State of Affairs
Kaur, N., & Sharma, S. (2018) · AMEI's Current Trends in Diagnosis & Treatment · doi:10.5005/jp-journals-10055-0028 · Cited by 2
Tamma, P. D., Miller, M. A., & Cosgrove, S. E. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-484ip · Cited by 3
Matusik, É., Lambiotte, F., Toné, A., & Lemtir, J. (2020) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2020.11.011 · Cited by 4
Pharmacological Interventions on Surgical Intensive Care Units Initiated by Pharmacists
Lee, J., Lee, E., Yeo, Y.-J., Oh, Y.-S., Hong, S., & Lee, J. M. (2021) · JOURNAL OF ACUTE CARE SURGERY · doi:10.17479/jacs.2021.1.1 · Cited by 2
Pajot, O., Lakhal, K., Lambert, J., Gros, A., Bruel, C., Boulain, T., Garot, D., Das, V., Timsit, J., Cerf, C., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11111664 · Cited by 2
Antimicrobial Stewardship in the Intensive Care Unit
Chen, I. H., Nicolau, D. P., & Kuti, J. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-21710-4_8 · Cited by 2
Niibe, Y., Suzuki, T., Yamazaki, S., Suzuki, T., Hattori, N., Nakada, T., & Ishii, I. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.02.017 · Cited by 2
Samb, A., Dierikx, T. H., Bijleveld, Y. A., de Haan, T. R., Hodiamont, C. J., van Leeuwen, E., van Kaam, A. H., Mathôt, R. A. A., & Visser, D. H. (2023) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-023-00163-3 · Cited by 2
Wenker, S. A. M., Alabdulkarim, N., Readman, J., Slob, E. M. A., Satta, G., Ali, S., Gadher, N., Shulman, R. I., & Standing, J. F. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae036 · Cited by 2
Shiqi, C., Chuhui, W., Yijing, Z., Qiu, Y., Jiaojiao, C., Chen, K., Qindong, S., Xiaoyan, Z., & Yalin, D. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05063-2 · Cited by 2
Intravenous Ampicillin/Sulbactam in Critically Ill Dogs has Variable Pharmacokinetics
Goggs, R. A. N., Robbins, S. N., Menard, J. M., Selman, J., Beverly, J. D., Kraus‐Malett, S., & Papich, M. G. (2025) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.70004 · Cited by 2
“These patients were 32% less likely to have positive clinical outcomes than those in whom PK-PD targets were attained (Roberts et al. 2014).”
Rao, Q., Zhu, H. Y., Lu, J., Zhu, H., Wu, F. Q., Zhou, J., Zhang, J., Wang, S., & Liu, M. (2025) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-025-01998-w · Cited by 2
“These include the percentage of time that free drug concentrations exceed the minimum inhibitory concentration ( f %T > MIC), the ratio of the area under the curve to MIC ( f AUC/MIC), and the ratio of trough concentration to MIC ( f Cmin/MIC) [15].”
Zurawska, M., Valadez, A., Harlan, E., Williamson, R., Scheetz, M. H., Neely, M. N., Yarnold, P. R., Kang, M., Donnelly, H. K., Martinez, F., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01760-25 · Cited by 2
Toullec, L., Dupouey, J., Vigne, C., Marsot, A., Allanioux, L., Blin, O., Léone, M., & Guilhaumou, R. (2017) · Therapies · doi:10.1016/j.therap.2017.02.003 · Cited by 2
Hypoalbuminaemia and Altered Protein Binding
Brink, A. J. (2017) · Springer eBooks · doi:10.1007/978-981-10-5336-8_5 · Cited by 2
Shoji, K., Saito, J., Oho, Y., Matsumoto, S., Aoki, S., Fukuda, A., Sakamoto, S., Kasahara, M., Capparelli, E. V., & Miyairi, I. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2398 · Cited by 2
Lodes, U., Troeger, U., Neuling, F., Jacob, D. A., & Meyer, F. P. (2019) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-1014-3451 · Cited by 2
Riggi, G., & Abbo, L. M. (2021) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-62116-2_21 · Cited by 4
PK / PD and the Drug Delivery Regimen for Infusion in the Critical Care Setting
Sime, F. B., & Roberts, J. A. (2021) · Wiley eBooks · doi:10.1002/9781119772767.ch10 · Cited by 2
Self-citation24th International Symposium on Infections in the Critically Ill Patient
Artigas, A., Carlet, J. M., Garnacho, J., Niederman, M. S., & Torres, A. (2019) · Medical Sciences · doi:10.3390/medsci7020023 · Cited by 3
Self-citationAl‐Shaer, M. H., Williams, R. G., Mousa, M. J., Alexander, K. M., Maguigan, K. L., Manigaba, K., Maranchick, N. F., Shoulders, B. R., Felton, T., Mathew, S. K., et al. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000993 · Cited by 2
van Gelder, T. G., Schweitzer, V. A., Uijtendaal, E. V., & Sikma, M. A. (2024) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001215 · Cited by 2
Broulíková, H. M., Wallage, J., Roggeveen, L. F., Fleuren, L. M., Guo, T., Elbers, P., & Bosmans, J. E. (2025) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-024-01257-9 · Cited by 2
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., Waele, J. J. D., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu403 · Cited by 2
Self-citationFocus on optimization of early antimicrobial therapy in ICU-acquired infections
Timsit, J., Paiva, J.-A., & Bassetti, M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4485-2 · Cited by 2
“Regarding beta-lactams, the DALI study showed over 500-fold differences in plasma drug concentrations [15].”
BackgroundSelf-citationRoberts, J. A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002862 · Cited by 2
Self-citationBrinkmann, A., & Frey, O. R. (2022) · Die Anaesthesiologie · doi:10.1007/s00101-022-01174-z · Cited by 2
“dosierung [10], sodass bereits vor vielen”
El‐Haffaf, I., Laverdière, J., Albert, M., Marsot, A., & Williamson, D. R. (2023) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2023-0109 · Cited by 1
Heffernan, A. J., Smedley, A., Stickley, T., Oomen, S., Carrigan, B., Heffernan, R., Woodall, H., Pinidiyapathirage, J. M., & Brumpton, K. (2023) · Australian Journal of Rural Health · doi:10.1111/ajr.13079 · Cited by 3
Antibiotics, Antivirals, and Antifungals in Critical Care
Shamshirsaz, A. A., & Vaught, A. “. J. (2024) · Wiley eBooks · doi:10.1002/9781119820260.ch19 · Cited by 1
Morath, B., Schultes, L., Frey, O. R., Röhr, A. C., Christow, H., Hoppe‐Tichy, T., Brinkmann, A., & Chiriac, U. (2024) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001253 · Cited by 1
Plasma Trough Concentrations of Beta‐Lactam Antibiotics in the Early Phase of Septic Shock
Hägglund, M., Brink, M., Martin, U. S., Bremell, D., & Svensson, C. J. (2025) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.70050 · Cited by 1
Farinella, A., Salvagno, M., Minini, A., Attanasio, L., Cunha, A., Menozzi, M., Saravia, A., Amado, F., Gorham, J., Hites, M., et al. (2025) · Life · doi:10.3390/life15050739 · Cited by 1
Self-citationDestache, C. J., Witherspoon, K., Yeates, C., Quimby, D. S., Ahmad, F., & Vivekanandan, R. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251339770 · Cited by 1
Intravenous Clarithromycin in Critically Ill Adults: A Population Pharmacokinetic Study
Shah, R. V., Kipper, K., Baker, E. H., Barker, C. I. S., Oldfield, I., Davidson, H., Swire, C. C., Philips, B. J., Johnston, A. E., Rhodes, A., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14060559 · Cited by 1
Self-citationLiang, B., Su, J., Wang, Y., Chen, L., Mo, Y., & Xie, B. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2025.07.016 · Cited by 1
Brust-Sisti, L. A., Hu, G.-Y., Bridgeman, M., Brunetti, L., & Gonzalez, J. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251346777 · Cited by 1
“6,32,33 Several population PK studies evaluating CRO probability of target attainment have been performed in critically ill patients, 6,31,34 showing that as the organism MIC increases, the likelihood of attaining the PK/PD target decreases with standard doses.”
Zhu, Z., Yang, T., Han, K., Liu, X., Yang, Y., & Pan, L. (2025) · Medicine · doi:10.1097/md.0000000000043460 · Cited by 1
“[6,7] Clinical practice factors, such as inappropriate prescribing and subtherapeutic dosing, create selective pressure for resistant organisms.”
Moreland-Head, L., Ausman, S. E., Rivera, C. G., Saleh, O. A., Jannetto, P. J., Wessel, R. J., & Barreto, E. F. (2025) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaf227 · Cited by 1
Weng, D., Ye, W., & Lv, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003679 · Cited by 1
Gatti, M., Grimaldi, P., Rinaldi, M., Siniscalchi, A., Tonetti, T., Viale, P., & Pea, F. (2025) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00324-0 · Cited by 2
Metadata
- Authors
- Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., Rello, J., Rhodes, A., Starr, T., Wallis, S. C., Lipman, J., Study, D., Roberts, J. A., Lipman, J., Starr, T., Wallis, S. C., Paul, S. K., Margarit Ribas, A., De Waele, J. J., De Crop, L., Spapen, H., Wauters, J., Dugernier, T., Jorens, P., Dapper, I., De Backer, D., Taccone, F. S., Rello, J., Ruano, L., Afonso, E., Alvarez-Lerma, F., Gracia-Arnillas, M. P., Fernandez, F., Feijoo, N., Bardolet, N., Rovira, A., Garro, P., Colon, D., Castillo, C., Fernado, J., Lopez, M. J., Fernandez, J. L., Arribas, A. M., Teja, J. L., Ots, E., Carlos Montejo, J., Catalan, M., Prieto, I., Gonzalo, G., Galvan, B., Blasco, M. A., Meyer, E., Del Nogal, F., Vidaur, L., Sebastian, R., Garde, P. M., Martin Velasco, M. D. M., Zaragoza Crespo, R., Esperatti, M., Torres, A., Montravers, P., Baldesi, O., Dupont, H., Mahjoub, Y., Lasocki, S., Constantin, J. M., Payen, J. F., Martin, C., Albanese, J., Malledant, Y., Pottecher, J., Lefrant, J.-Y., Jaber, S., Joannes-Boyau, O., Orban, C., Ostermann, M., McKenzie, C., Berry, W., Smith, J., Lei, K., Rubulotta, F., Gordon, A., Brett, S., Stotz, M., Templeton, M., Rhodes, A., Ebm, C., Moran, C., Kaukonen, K.-M., Pettila, V., Dimopoulos, G., Koulenti, D., Xristodoulou, A., Theodorou, V., Kouliatsis, G., Sertaridou, E., Anthopoulos, G., Choutas, G., Rantis, T., Karatzas, S., Balla, M., Papanikolaou, M., Myrianthefs, P., Gavala, A., Fildisis, G., Koutsoukou, A., Kyriakopoulou, M., Petrochilou, K., Kompoti, M., Michalia, M., Clouva-Molyvdas, F.-M., Gkiokas, G., Nikolakopoulos, F., Psychogiou, V., Malliotakis, P., Akoumianaki, E., Lilitsis, E., Koulouras, V., Nakos, G., Kalogirou, M., Komnos, A., Zafeiridis, T., Chaintoutis, C., Arvaniti, K., Matamis, D., Chaintoutis, C., Kydona, C., Gritsi-Gerogianni, N., Giasnetsova, T., Giannakou, M., Soultati, I., Chytas, I., Antoniadou, E., Antipa, E., Lathyris, D., Koukoubani, T., Paraforou, T., Spiropoulou, K., Bekos, V., Spring, A., Kalatzi, T., Nikolaou, H., Laskou, M., Strouvalis, I., Aloizos, S., Kapogiannis, S., Soldatou, O., Bassetti, M., Adembri, C., Villa, G., Giarratano, A., Maurizio Raineri, S., Cortegiani, A., Montalto, F., Strano, M. T., Ranieri, V. M., Sandroni, C., De Pascale, G., Molin, A., Pelosi, P., Montagnani, L., Urbino, R., Mastromauro, I., De Rosa, F. G., Ranieri, V. M., Cardoso, T., Afonso, S., Goncalves-Pereira, J., Baptista, J. P., Akova, M., & Ozveren, A.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- The University of Queensland (AU)
- Ghent University Hospital (BE)
- Centre Hospitalier Universitaire de Nîmes (FR)
- University General Hospital Attikon (GR)
- Sorbonne Paris Cité (FR)
- St George's, University of London (GB)
- University of Palermo (IT)
- University of Genoa (IT)
- Hacettepe University (TR)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-14
- Volume
- 58
- Issue
- 8
- Pages
- 1072-1083
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2101416655
- Cited by
- 1,090
- References
- 31
- Citations by year
- 2026: 75 · 2025: 98 · 2024: 83 · 2023: 125 · 2022: 115 · 2021: 125 · 2020: 86 · 2019: 84 · 2018: 69 · 2017: 71 · 2016: 66 · 2015: 57 · 2014: 34
- FWCI
- 55.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NIHR/CS/009/007)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- beta-lactam antibiotics, antibiotic dosing, critically ill patients, intensive care unit, pharmacokinetics, pharmacodynamics, free drug concentration, time above MIC, patient outcomes
- MeSH terms
- Aged, Anti-Bacterial Agents, Bacterial Infections, Blood Chemical Analysis, Female, Humans, Intensive Care Units, International Cooperation, Male, Microbial Sensitivity Tests, Middle Aged, Prospective Studies, Models, Statistical, Critical Illness, Treatment Outcome, beta-Lactams
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.